HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Brenda Banwell Selected Research

Biomarkers (Surrogate Marker)

10/2018Neurotoxicity after CTL019 in a pediatric and young adult cohort.
8/2015Update on biomarkers in neuromyelitis optica.
7/2014Defining the clinical course of multiple sclerosis: the 2013 revisions.
6/2009Pediatric central nervous system inflammatory demyelination: acute disseminated encephalomyelitis, clinically isolated syndromes, neuromyelitis optica, and multiple sclerosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Brenda Banwell Research Topics

Disease

55Multiple Sclerosis
04/2024 - 03/2005
21Demyelinating Diseases (Demyelinating Disease)
02/2024 - 02/2007
14Neuromyelitis Optica (Devic's Disease)
01/2023 - 06/2009
7Acute Disseminated Encephalomyelitis (Postinfectious Encephalomyelitis)
11/2020 - 02/2007
6Infections
01/2023 - 05/2011
5Optic Neuritis (Retrobulbar Neuritis)
05/2022 - 06/2009
4Neuroinflammatory Diseases
03/2024 - 07/2014
3COVID-19
01/2023 - 11/2021
3Ganglion Cysts (Ganglion)
05/2022 - 12/2014
3Disease Progression
11/2021 - 10/2010
3Brain Diseases (Brain Disorder)
10/2018 - 06/2009
3Seizures (Absence Seizure)
10/2018 - 01/2010
3Encephalitis (Encephalitis, Rasmussen)
07/2014 - 04/2007
2Pancreatitis
04/2024 - 12/2021
2Brain Edema (Cerebral Edema)
11/2023 - 11/2023
2Fatigue
01/2022 - 01/2019
2Atrophy
11/2021 - 01/2020
2Cognitive Dysfunction
11/2021 - 10/2010
2Muscle Weakness
10/2021 - 03/2009
2Muscular Diseases (Myopathy)
10/2021 - 11/2017
2Myelitis
10/2021 - 08/2016
2Opsoclonus-Myoclonus Syndrome (Kinsbourne Syndrome)
07/2014 - 04/2007
2Central Nervous System Diseases (CNS Diseases)
07/2014 - 10/2013
2Guillain-Barre Syndrome
06/2014 - 04/2007
2Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker)
06/2010 - 03/2009
2GM2 Gangliosidoses (GM2 Gangliosidosis)
08/2009 - 11/2006
2Neurodegenerative Diseases (Neurodegenerative Disease)
08/2009 - 11/2006
2Alexander Disease (Alexander's Disease)
03/2005 - 03/2005
1Neoplasms (Cancer)
03/2024
1Brain Hypoxia (Cerebral Hypoxia)
11/2023
1Intracranial Hypertension
11/2023
1Respiratory Tract Infections (Respiratory Tract Infection)
12/2021
1Alopecia (Baldness)
12/2021
1Abdominal Pain (Pain, Abdominal)
12/2021
1Nasopharyngitis
12/2021
1Rhabdomyolysis
10/2021
1Myalgia
10/2021
1Leber Hereditary Optic Atrophy (Leber's Hereditary Optic Neuropathy)
01/2021
1Psychotic Disorders (Schizoaffective Disorder)
11/2020
1Weight Loss (Weight Reduction)
01/2019
1Cytokine Release Syndrome
10/2018
1Body Weight (Weight, Body)
01/2018
1Leukopenia
01/2018
1Supraventricular Tachycardia
01/2018
1Central Core Myopathy (Central Core Disease)
11/2017
1Malignant Hyperthermia
11/2017
1Congenital Structural Myopathies (Centronuclear Myopathy)
11/2017
1Diffuse Brain Injuries (Diffuse Brain Injury)
07/2015

Drug/Important Bio-Agent (IBA)

16Myelin-Oligodendrocyte GlycoproteinIBA
02/2024 - 07/2012
14AntibodiesIBA
01/2023 - 04/2004
9Immunoglobulin G (IgG)IBA
11/2023 - 04/2004
6AutoantibodiesIBA
03/2024 - 02/2007
6InterferonsIBA
01/2022 - 07/2013
5Fingolimod Hydrochloride (FTY720)FDA Link
01/2022 - 01/2018
4Retinaldehyde (Retinal)IBA
12/2022 - 12/2014
4Biomarkers (Surrogate Marker)IBA
10/2018 - 06/2009
4AntigensIBA
11/2013 - 04/2004
3teriflunomideIBA
04/2024 - 12/2021
3AdipokinesIBA
01/2022 - 01/2019
3Creatine Kinase (Creatine Phosphokinase)IBA
12/2021 - 03/2009
3Rituximab (Mabthera)FDA Link
10/2021 - 07/2014
3EpitopesIBA
12/2014 - 01/2008
2Glial Fibrillary Acidic ProteinIBA
03/2024 - 03/2005
2Intravenous Immunoglobulins (IVIG)FDA Link
11/2023 - 04/2007
2SteroidsIBA
11/2023 - 06/2015
2EnzymesIBA
12/2021 - 10/2021
2anti-aquaporin 4 autoantibodyIBA
10/2021 - 01/2019
2DNA (Deoxyribonucleic Acid)IBA
01/2021 - 03/2005
2Interferon beta-1aFDA Link
01/2018 - 07/2013
2Protons (Proton)IBA
07/2015 - 05/2013
2Proteins (Proteins, Gene)FDA Link
09/2014 - 01/2008
2Peptides (Polypeptides)IBA
11/2013 - 02/2007
2Oligoclonal BandsIBA
05/2011 - 06/2009
2Vitamin DFDA LinkGeneric
05/2011 - 02/2011
2G(M2) Ganglioside (Ganglioside GM2)IBA
08/2009 - 11/2006
2beta-N-AcetylhexosaminidasesIBA
08/2009 - 11/2006
1COVID-19 VaccinesIBA
04/2022
1VaccinesIBA
04/2022
1AdiponectinIBA
10/2021
1ImmunosorbentsIBA
10/2021
1Protein Isoforms (Isoforms)IBA
10/2021
1Electron Transport Complex III (Coenzyme Q-Cytochrome-c Reductase)IBA
01/2021
1GadoliniumIBA
01/2020
1SmokeIBA
01/2019
1CytokinesIBA
10/2018
1tisagenlecleucelIBA
10/2018
1Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA
11/2017
1Potassium Channels (Potassium Channel)IBA
09/2014
1N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
07/2014

Therapy/Procedure

20Therapeutics
11/2023 - 05/2005
3Immunomodulation
01/2020 - 03/2005
2Plasma Exchange
11/2023 - 06/2015
2Ketogenic Diet
01/2023 - 01/2022
1Activities of Daily Living (ADL)
09/2023
1Personal Protective Equipment
01/2023
1Continuity of Patient Care
04/2022
1Off-Label Use
11/2021
1Injections
11/2021
1Duration of Therapy
10/2021
1Immunotherapy
01/2019